Результаты поиска

Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview.

Although the concept of precision medicine, in which healthcare is tailored to the molecular and clinical characteristics of each individual, is not new, its implementation in clinical practice has been heterogenous. In some medical specialties, precision medicine has gone from being just a promise to a reality that achieves better patient outcomes. This is a fact if we consider, for example, the great advances made in the genetic diagnosis and subsequent treatment of countless hereditary diseases, such as cystic fibrosis, which have improved the life expectancy of many of the affected childre…

Driving towards Precision Medicine for angioedema without wheals.

Evidence accumulated over the last two decades indicates that recurrent angioedema without wheals constitutes a diverse family of disorders … terrelate its many diverse aspects seems unrealistic. Similar to other rare and chronic diseases, a Precision Medicine approach, discovering the right target and giving "the right drug, for the right patient, at the right time, every time" seems the optimal future practice. Herein, we review recent data challenging and dictating the need for a switch of angioedema r …

Resolving complexity in mitochondrial disease: Towards precision medicine.

Mitochondrial diseases, caused by mutations in either the nuclear or mitochondrial genomes (mtDNA), are the most common form of inherited neurometabolic disorders. They are remarkably heterogeneous, both in their clinical presentation and genetic etiology, presenting challenges for diagnosis, clinical management and elucidation of molecular mechanism. The multifaceted nature of these diseases, compounded by the unique characteristics of mitochondrial genetics, cement their space in the field of complex disease. In this review we examine the m.3243A>G variant, one of the most prevalent mitochon

Precision medicine and monoclonal antibodies: breach of promise?

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… References 1 Psaty BM Dekkers OM Cooper RS Comparison of 2 treatment models: precision medicine and preventive medicine. JAMA 2018 320 751 2 10.1001/jama.2018.8377 30054607 2 Collins FS Varmus H A new initiative on precision medicine. … Med Decis Making 2010 30 328 40 10.1177/0272989X09347014 20086232 PMC4598076 7 Vegter MW Towards precision medicine; a new biomedical cosmology. …

NSG mice as hosts for oncological precision medicine.

Patient-derived xenograft (PDX) models have been rediscovered as meaningful research tool. By using severely immunodeficient mice, high-engr … tive. Consequently, such dose finding and tolerance tests constitute a necessity for similar cancer precision medicine approaches.

Non-REM Parasomnia: The Promise of Precision Medicine.

Our understanding of non-REM parasomnias is just beginning to unfold the potential biomarkers and underlying pathophysiologic processes that lead to these events. Biomarkers need further investigation and will help us to understand better ways to develop risk models and possible mechanisms. Similarly, as we develop more accurate pathophysiologic-based diagnostic testing for non-REM parasomnias, we will begin the evolution toward a physiologic-based classification scheme that aids the application of precision medicine. This article explores currently known characteristics and exploratory featur…

Precision Medicine and Personalized Approach to Renal Transplantation.

Successful renal transplantation is a highly effective endeavor that improves and prolongs the lives of patients with chronic kidney disease … unt to optimize individual outcomes. The personalized approach to renal transplantation, which uses precision medicine concepts, identifies unique aspects of candidates/recipients that require consideration using a combination of time-honored guidelines, emerging concepts, new medications, and refinements of care.

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

Antiplatelet therapy with P2Y12-receptor inhibitors has become the cornerstone of medical treatment in patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI). With over 100 million prescriptions filled since its approval, clopidogrel is the most widely used P2Y12-receptor inhibitor. Dual antiplatelet therapy with clopidogrel plus aspirin has been associated with a lower rate of major cardiovascular events in patients after PCI than aspirin monotherapy. However, an alarmingly high number of clopidogrel-treated patients experience adverse thrombotic events. I

[Interventional cardiology in 2035: Towards a precision medicine].

Interventional cardiology has continued to progress over the years. Once limited to coronary procedures, it's now evolving toward structural cardiology. Along technological challenges that will gradually being overcome, multimodal imaging is increasingly being integrated to guide procedures, together with artificial intelligence and data analysis, enabling personalized patient care through a global cardiovascular interventional medicine approach.

Infective endocarditis and precision medicine: A narrative review.

Infective endocarditis (IE) remains a life-threatening condition with high global morbidity and mortality, demanding more effective strategies for early detection and management. Precision medicine offers a transformative approach, starting with comprehensive risk profiling that combines genetic predisposition, preexisting comorbidities, and lifestyle factors such as intravenous drug use and oral hygiene. This paradigm extends to point-of-care diagnostics and culminates in targeted, patient-specific treatment strategies. To explore its potential in IE, we systematically searched PubMed, Scopus…

Precision Medicine for Somatic Mutation-Driven Vascular Anomalies.

Vascular anomalies, including proliferative vascular tumours and structural malformations, are largely driven by postzygotic somatic mutations that constitutively activate key signalling pathways, mainly the PI3K/AKT/mTOR and RAS/MAPK pathways. This molecular understanding has shifted clinical management from empiric interventions towards precision medicine. In this review, the interactions between somatic mosaicism, germline predispositions (e.g., PTEN hamartoma tumour syndrome), and microenvironmental risk factors in the context of lesional progression are described. We synthesized data on g…

Precision medicine for Alzheimer's disease in Down syndrome.

INTRODUCTION: Down syndrome (DS) exhibits a genetic form of Alzheimer's disease (AD). We used a blood-based proteomic algorithm to predict cognitive status, treatment responders, and change to vitamin E in DS adults from a completed clinical trial, "Vitamin E in Aged Persons with Down Syndrome," which originally showed no significant cognitive benefit using the primary endpoint cognition (Brief Praxis Test [BPT]). METHODS: Plasma and extracellular vesicle (EV; astrocytic and neuronal) biomarkers were assayed at baseline and 36 months (n = 138 each). Cognitive response was measured using combi

New Frontiers of Skin Ultrasound in Precision Medicine.

Ultrasound has emerged as a versatile, non-invasive imaging technique in dermatology, offering real-time, high-resolution visualization of cutaneous structures. By employing high- and ultra-high-frequency probes, skin ultrasound enables detailed assessment of the epidermis, dermis, and subcutaneous tissue, while Doppler modalities provide complementary information on vascularity. This review synthesizes current evidence on the role of ultrasound across the spectrum of dermatologic conditions, including malignant and benign tumors, inflammatory skin disorders, connective tissue diseases, and co

Revolutionizing anticoagulation: Nanoengineered therapies and precision medicine approaches.

With the advancement of therapeutic concepts, early intervention with antithrombotic therapy for patients at potential thrombotic risk is becoming more proactive. Anticoagulant therapy, a critical component of antithrombotic treatment, thus plays a key role in the prevention and treatment of cardiovascular diseases. Unfortunately, existing anticoagulation treatments still face many challenges, including abnormal bleeding, allergic reactions, and drug resistance. To identify novel technologies for addressing these issues and explore the latest research developments in the field of anticoagulati